Association between SSRI use and fractures and the effect of confounding by indication [5]

Archives of Internal Medicine

Volumn 167, Issue 21, 2007, Pages 2369-2370

  Ziere, Gijsbertus ^a   Dieleman, Jeanne P ^b   Van Der Cammen, Tischa J M ^b   Stricker, Bruno H Ch ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

BONE STRENGTH; DEPRESSION; DISEASE ASSOCIATION; FOLLOW UP; FRACTURE; FRAGILITY FRACTURE; HUMAN; LETTER; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK FACTOR;

EID: 36549073582     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.167.21.2369-b     Document Type: Letter

References (5)

1. Richards JB, Papaioannou A, Adachi JD, et al; Candian Multicentre Osteoporosis Study Research Group. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med. 2007;167(2):188-194.
2. Whooley MA, Kip KE, Cauley JA, et al. Depression, falls, and risk of fracture in older women. Arch Intern Med. 1999;159(5):484-490.
3. Hybels CF, Blazer DG. Epidemiology of late-life mental disorders. Clin Geriatr Med. 2003;19(4):663-696.
4. Cummings SR, Nevitt MC, Browner WS, et al; Study of Osteoporotic Fractures Research Group. Risk factors for hip fracture in white women. N Engl J Med. 1995;332(12):767-773.
5. Schneeweiss S, Wang PS. Association between SSRI use and hip fractures and the effect of residual confounding bias in claims database studies. J Clin Psychopharmacol. 2004;24(6):632-638.